Zofran and Placental infarction - a phase IV clinical study of FDA data
Summary:
Placental infarction is reported as a side effect among people who take Zofran (ondansetron hydrochloride), especially for people who are 30-39 old, also take Coumadin, and have Deep venous thrombosis.
The phase IV clinical study analyzes which people have Placental infarction when taking Zofran. It is created by eHealthMe based on reports of 93,713 people who have side effects when taking Zofran from the FDA, and is updated regularly.
What is Zofran?
Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.
What is Placental infarction?
Placental infarction (interruption of blood supply to a part of the placenta, causing its cells to die) is found to be associated with 46 drugs and 120 conditions by eHealthMe. Check the latest studies of Placental infarction.
93,713 people reported to have side effects when taking Zofran.
Among them, 18 people (0.02%) have Placental infarction.

Among these 18 people:
What is the age of people who have Placental infarction when taking Zofran? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 100 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 0.0 %
What are other drugs people take besides Zofran? *
- Xanax: 17 people, 94.44%
- Demerol: 17 people, 94.44%
- Ambien: 17 people, 94.44%
- Ativan: 17 people, 94.44%
- Coumadin: 17 people, 94.44%
- Lovenox: 16 people, 88.89%
- Pitocin: 16 people, 88.89%
- Tylenol: 16 people, 88.89%
- Dilaudid: 13 people, 72.22%
- Percocet: 13 people, 72.22%
What are other side effects people have besides Placental infarction? *
- White Blood Cell Count Increased: 17 people, 94.44%
- Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 17 people, 94.44%
- Alanine Aminotransferase Increased: 17 people, 94.44%
- Aspartate Aminotransferase Increased: 17 people, 94.44%
- Blood Albumin Decreased: 17 people, 94.44%
- Blood Alkaline Phosphatase Increased: 17 people, 94.44%
- Blood Magnesium Decreased: 17 people, 94.44%
- Chorioamnionitis (inflammation of the fetal membranes (amnion and chorion) due to a bacterial infection): 17 people, 94.44%
- Fatigue (feeling of tiredness): 17 people, 94.44%
- Gingival Bleeding (bleeding gums): 17 people, 94.44%
What are the existing conditions these people have? *
- Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 5 people, 27.78%
- Vomiting In Pregnancy: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Zofran and have Placental infarction?
- Check whether Placental infarction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zofran:
- Zofran (94,987 reports)
Placental infarction treatments and more:
- Placental infarction (302 reports)
How severe was Placental infarction and when was it recovered:
Expand to all the drugs that have ingredients of ondansetron hydrochloride:
Sub-studies by age:
0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zofran:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Placental infarction:
- Placental infarction (46 drugs)
Browse all the conditions that are associated with Placental infarction:
- Placental infarction (120 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ondansetron hydrochloride (the active ingredients of Zofran) and Zofran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ocaliva cause Neck Pain? - now
- Could Co-Codamol cause Irritable Bowel Syndrome? - 22 seconds ago
- Could Cardizem La cause Pressure Ulcer? - 22 seconds ago
- Drug interactions of Iron Dextran and Venofer - 33 seconds ago
- Could Carboplatin cause Enterobacter Infection? - 41 seconds ago
- Drug interactions of Tarceva and Q10 - 57 seconds ago
- Drug interactions of Ipratropium Bromide and Omacor - 57 seconds ago
- Univasc vs. Tenormin, side effect and effectiveness comparison - a minute ago
- Could Evrysdi cause Death? - a minute ago
- Could Tavist cause Fever? - a minute ago